Canada In Vivo Cro Market Size & Outlook, 2024-2030
Related Markets
Canada in vivo cro market highlights
- The Canada in vivo cro market generated a revenue of USD 437.7 million in 2023 and is expected to reach USD 745.5 million by 2030.
- The Canada market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
- In terms of segment, small molecule was the largest revenue generating modality type in 2023.
- Large Molecule is the most lucrative modality type segment registering the fastest growth during the forecast period.
In vivo cro market data book summary
| Market revenue in 2023 | USD 437.7 million |
| Market revenue in 2030 | USD 745.5 million |
| Growth rate | 7.9% (CAGR from 2023 to 2030) |
| Largest segment | Small molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | IQVIA Holdings Inc, JSR Corp, Taconic Biosciences, Evotec SE, Janvier Labs, Charles River Laboratories International Inc, Icon PLC, Labcorp Holdings Inc, PAREXEL, GemPharmatech, PsychoGenics, Biocytogen, SMO-Group |
Other key industry trends
- In terms of revenue, Canada accounted for 9.5% of the global in vivo cro market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. in vivo cro market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 3,003.9 million by 2030.
Small molecule was the largest segment with a revenue share of 63.63% in 2024. Horizon Databook has segmented the Canada in vivo cro market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
Canada’s in vivo CRO market is anticipated to witness lucrative growth from 2022 to 2030. Growth in the country can be underpinned by the presence of a well-established healthcare system and increasing number of pharmaceutical & biotech companies, supported by both the public & private sectors.
Canada holds around 2.1% of the global pharmaceutical sales market, positioning it as the 9th largest market worldwide. This sector benefits from highly trained scientists, a well-educated workforce, business-friendly government policies, and high R&D operations.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In Vivo CRO Market Scope
In Vivo CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada in vivo cro market size, by modality type, 2018-2030 (US$M)
Canada In Vivo CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
